Loading...

China Oncology

30 June 2022, Volume 32 Issue 6
Cover and contents

2022 Issue 6 Cover

Abstract ( 111) PDF (3357KB) ( 277 )

Contents of Issue 6, 2022

2022, 32 (6): 2-2.

Abstract ( 73) PDF (13707KB) ( 231 )

Specialists' Article

Epidemiological analysis of real-world immune checkpoint inhibitor-related pneumonitis in Chinese patients with lung cancer

WU Jianhui, CHU Xiangling, WANG Liqiang, LIN Xinqing, XIE Xiaohong, XIE Mengqing, ZHAO Jing, DENG Haiyi, YANG Yilin, QIU Guihuan, ZHOU Maolin, SUN Ni, LI Ru, CHEN Ying, DENG Jiaxi, ZENG Chen, PAN Bolin, QIN Yinyin, LIU Ming, SU Chunxia, ZHOU Chengzhi

2022, 32 (6): 469-477. doi: 10.19401/j.cnki.1007-3639.2022.06.001

Abstract ( 449) PDF (1543KB) ( 790 ) HTML ( 980 )

Specialists' Commentary

Current status and future directions of immunotherapy for advanced non-small cell lung cancer

SU Chunxia, ZHOU Caicun

2022, 32 (6): 478-486. doi: 10.19401/j.cnki.1007-3639.2022.06.002

Abstract ( 755) PDF (1164KB) ( 1326 ) HTML ( 3605 )

Treatment of unresectable locally advanced non-small cell lung cancer in the era of immunotherapy: status and prospects

YU Silai, NI Jianjiao, ZHU Zhengfei

2022, 32 (6): 487-498. doi: 10.19401/j.cnki.1007-3639.2022.06.003

Abstract ( 454) PDF (1219KB) ( 744 ) HTML ( 471 )

COVID-19 and systemic anti-cancer therapy

HU Xichun, HU Zhihuang, WANG Biyun, WANG Jialei, TAO Rong, ZHANG Jian, GUO Weijian, CHEN Jie, LUO Zhiguo, LI Ting, HUANG Mingzhu, QIU Lixin, SANG Youzhou

2022, 32 (6): 499-511. doi: 10.19401/j.cnki.1007-3639.2022.06.004

Abstract ( 570) PDF (1226KB) ( 843 ) HTML ( 250 )

Detection of CD30 expression in lymphomas: status and challenges

LI Xiaoqiu, CD30 Positive Lymphoma Pathology Expert Group

2022, 32 (6): 512-518. doi: 10.19401/j.cnki.1007-3639.2022.06.005

Abstract ( 453) PDF (1220KB) ( 911 ) HTML ( 143 )

Article

Analysis of current status of cervical cancer incidence and mortality in Shanghai, 2016 and trends of 2002-2016

PANG Yi, WU Chunxiao, GU Kai, BAO Pingping, WANG Chunfang, SHI Liang, GONG Yangming, XIANG Yongmei, DOU Jianming, WU Mengyin, FU Chen, SHI Yan

2022, 32 (6): 519-526. doi: 10.19401/j.cnki.1007-3639.2022.06.006

Abstract ( 311) PDF (1324KB) ( 661 ) HTML ( 45 )

ZDHHC12 regulates tumor properties through YAP1 in glioblastoma

ZHANG Qixiang, YOU Yongping

2022, 32 (6): 527-534. doi: 10.19401/j.cnki.1007-3639.2022.06.007

Abstract ( 374) PDF (1513KB) ( 606 ) HTML ( 34 )

Neddylation modification regulates lamin B1 expression in breast cancer

JIA Xiaoqing, SUN Xiaoyin, JIANG Beiqi, MEI Zhangyi, FU Yun, ZHUANG Zhigang

2022, 32 (6): 535-541. doi: 10.19401/j.cnki.1007-3639.2022.06.008

Abstract ( 250) PDF (1698KB) ( 462 ) HTML ( 11 )

Surgical treatment of esophagotracheal fistula caused by neoadjuvant chemotherapy for locally advanced esophageal cancer: a case report

MA Xiao, XIANG Jiaqing, MA Longfei

2022, 32 (6): 542-544. doi: 10.19401/j.cnki.1007-3639.2022.06.009

Abstract ( 216) PDF (1461KB) ( 455 ) HTML ( 20 )

Guideline and Consensus

China Anti-Cancer Association guideline for diagnosis and treatment of neuroendocrine neoplasm (2022 edition)

Society of Neuroendocrine Neoplasm of China Anti-Cancer Association

2022, 32 (6): 545-579. doi: 10.19401/j.cnki.1007-3639.2022.06.010

Abstract ( 1048) PDF (1309KB) ( 2191 ) HTML ( 2822 )

中国癌症杂志
    Database Indexing
  • A Guide to the Core Journals of China
  • Chinese Science Citation Database (CSCD)
  • China National Knowledge Infrastructure (CNKI)
  • Chinese Sci-tech Paper and Citation Database (CSTPCD)
  • Outsanding S&T Journals of China (2020) (F5000)
  • World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
  • SCOPUS
  • EMBASE
  • DOAJ
  • Chemical Abstracts (CA)
  • Japan Science and Technology Database (JST)
  • The Western Pacific Region Index Medicus (WPRIM)
  • EBSCO
  • Index of Copernicus International (ICI)

Competent Authorities

 The Ministry of Education of the People’s Republic of China

Sponsored by

 Fudan University Shanghai Cancer Center

Edited by

 Editorial Board of China Oncology

Editor-in-Chief

 SHAO Zhimin

Honorary Editor-in-Chief

 TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

 Shanghai Ouyang Printing Co., Ltd.

WeChat